Literature DB >> 23353130

Bladder function after modified posterior exenteration for primary gynecological cancer.

Kazuyoshi Kato1, Shinichi Tate, Kyoko Nishikimi, Makio Shozu.   

Abstract

OBJECTIVE: Bladder dysfunction caused by autonomic nerve injury is a well-recognized complication of pelvic surgery. Modified posterior exenteration with or without nerve preservation was performed in patients with primary ovarian, tubal, peritoneal, and endometrial cancer. The aim of this retrospective study was to evaluate the impact of this surgical technique on bladder function.
METHODS: Among the 60 consecutive patients in whom modified posterior exenteration was performed, bilateral and unilateral nerve-sparing surgeries were performed in 43 (72%) and 15 (25%) patients, respectively. In the remaining 2 patients (3%), the pelvic autonomic nerves on both sides were sacrificed. Symptoms and bladder function after bilateral or unilateral nerve-sparing surgery were analyzed using standardized questionnaires before and 3 and 6 months after surgery.
RESULTS: All patients with bilateral nerve-sparing surgery had sufficient micturition from the early postoperative period. Though 40% of the patients with unilateral nerve-sparing surgery had difficulty in spontaneous voiding and needed intermittent catheterization, voiding ability of them improved and no self-catheterization was required 3 months after surgery. The assessment of patient questionnaires suggested that bladder function was acceptable in both groups at 6 months. Patients with bilateral nerve-sacrificing surgery complained of neurogenic bladder requiring self-catheterization even 6 months after surgery.
CONCLUSIONS: This preliminary study showed that preservation of bladder function after modified posterior exenteration was feasible with a nerve sparing approach and that standardized outcome measures could be used to monitor this. However, careful follow-up is required. Future larger studies are needed to investigate pelvic autonomic nerve function.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23353130     DOI: 10.1016/j.ygyno.2013.01.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours.

Authors:  Bernhard Liedl; Wael Y Khoder; Brigitte Ruhdorfer-Metz; Christian G Stief; Raphaela Waidelich
Journal:  Int Urogynecol J       Date:  2014-03-15       Impact factor: 2.894

Review 2.  Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Authors:  Shaun Hiu; Andrew Bryant; Ketankumar Gajjar; Patience T Kunonga; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

3.  Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection.

Authors:  Giuseppe Vizzielli; Carmine Conte; Massimo Romano; Anna Fagotti; Barbara Costantini; Claudio Lodoli; Salvatore Gueli Alletti; Khaled Gaballah; Fabio Pacelli; Alfredo Ercoli; Giovanni Scambia; Valerio Gallotta
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

4.  Early oral feeding is safe and useful after rectosigmoid resection with anastomosis during cytoreductive surgery for primary ovarian cancer.

Authors:  Kazuyoshi Kato; Kohei Omatsu; Sanshiro Okamoto; Maki Matoda; Hidetaka Nomura; Terumi Tanigawa; Yoichi Aoki; Mayu Yunokawa; Hiroyuki Kanao
Journal:  World J Surg Oncol       Date:  2021-03-15       Impact factor: 2.754

5.  Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration.

Authors:  Kazuyoshi Kato; Kyoko Nishikimi; Shinichi Tate; Takako Kiyokawa; Makio Shozu
Journal:  World J Surg Oncol       Date:  2015-07-31       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.